Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Seevix Material Sciences Ltd. is pursuing patent protection in the Biotechnology & Pharmaceuticals technology area. The company currently has 2 pending office actions, which are distributed across 2 distinct examiners. This distribution shows that the company's current patent applications are being evaluated independently by different individuals at the patent office.
The prosecution activity is spread across 2 distinct art units, reflecting a breadth of technical focus within the biotechnology field. SWIFT, CANDICE LEE is the busiest examiner for the portfolio, currently managing 1 pending office action. This represents exactly half of the 2 pending office actions currently on record for the company.
Practitioners should note that the involvement of 2 distinct examiners and 2 distinct art units requires a flexible prosecution strategy. While SWIFT, CANDICE LEE handles 1 pending matter, the other action is subject to the standards of a different examiner and art unit. This structure means the company must maintain consistency across 2 pending office actions in the Biotechnology & Pharmaceuticals sector.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (50%) |
| Double-patenting + other | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SWIFT, CANDICE LEE | 1 | 57.5% | +36.0% |
| LIU, TRACY | 1 | 54.5% | +27.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18014547 | HIGHLY POROUS SPIDER SILK FIBERS | SWIFT, CANDICE LEE | 36d overdue |
| 17972020 | MODIFIED SPIDER SILK FIBER AND USE THEREOF | LIU, TRACY | 29d overdue |
| Art Unit | Apps |
|---|---|
| 1657 | 1 |
| 1614 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18014547 | HIGHLY POROUS SPIDER SILK FIBERS | SWIFT, CANDICE LEE | 1657 | §112 | Final Rejection | 36d overdue | Pending | Jan 05, 2023 |
| 17972020 | MODIFIED SPIDER SILK FIBER AND USE THEREOF | LIU, TRACY | 1614 | §103DP | Final Rejection | 29d overdue | Pending | Oct 24, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial